Thus, the LINC02362/hsa-miR-18a-5p/FDX1 axis represents a novel pathway that drives cuprotosis, suppresses metastasis, and enhances sensitivity to oxaliplatin in HCC (116). Here, FDX1 is linked to hepatocellular carcinoma.